Filter News
Area of Research
- (-) Fusion and Fission (3)
- (-) Neutron Science (8)
- Biology and Environment (26)
- Clean Energy (16)
- Computational Biology (1)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Materials (5)
- Materials for Computing (4)
- National Security (3)
- Nuclear Science and Technology (1)
- Supercomputing (27)
News Type
News Topics
- (-) Coronavirus (8)
- (-) Simulation (3)
- 3-D Printing/Advanced Manufacturing (9)
- Advanced Reactors (7)
- Artificial Intelligence (7)
- Big Data (2)
- Bioenergy (7)
- Biology (5)
- Biomedical (12)
- Biotechnology (1)
- Buildings (1)
- Chemical Sciences (6)
- Clean Water (2)
- Climate Change (1)
- Composites (2)
- Computer Science (14)
- Critical Materials (1)
- Cybersecurity (1)
- Decarbonization (4)
- Energy Storage (10)
- Environment (10)
- Exascale Computing (1)
- Fossil Energy (2)
- Frontier (2)
- Fusion (22)
- Grid (2)
- High-Performance Computing (4)
- Isotopes (1)
- ITER (6)
- Machine Learning (3)
- Materials (14)
- Materials Science (24)
- Mathematics (1)
- Microscopy (4)
- Nanotechnology (11)
- National Security (2)
- Net Zero (1)
- Neutron Science (99)
- Nuclear Energy (29)
- Partnerships (3)
- Physics (10)
- Polymers (1)
- Quantum Computing (1)
- Quantum Science (7)
- Security (3)
- Space Exploration (3)
- Summit (6)
- Sustainable Energy (6)
- Transportation (7)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory hosted the second 2023 cohort of the International Atomic Energy Agency’s Lise Meitner Programme in October.
As renewable sources of energy such as wind and sun power are being increasingly added to the country’s electrical grid, old-fashioned nuclear energy is also being primed for a resurgence.
A method using augmented reality to create accurate visual representations of ionizing radiation, developed at ORNL, has been licensed by Teletrix, a firm that creates advanced simulation tools to train the nation’s radiation control workforce.
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.
COVID-19 has upended nearly every aspect of our daily lives and forced us all to rethink how we can continue our work in a more physically isolated world.